Christopher Dolan

Title: Christopher Dolan: Innovator in Nucleic Acid Engineering

Introduction

Christopher Dolan is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of systems and methods for engineering nucleic acid constructs. His innovative approach has the potential to advance genetic modifications in various organisms.

Latest Patents

Dolan holds a patent for "Systems and methods for engineering nucleic acid constructs using scoring techniques." This patent outlines a method for defining a nucleic acid construct for integration at a specific locus in an organism. The process involves receiving nucleic acid requests that specify genetic changes, expanding these requests into component polynucleotides, and arranging them into different configurations. Each configuration is scored based on the presence of source constructs, leading to the selection of the most suitable arrangement for amplification.

Career Highlights

Throughout his career, Christopher Dolan has worked with prominent companies in the biotechnology sector, including Amyris Biotechnologies, Inc. and Amyris, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Dolan has collaborated with notable colleagues such as Darren M. Platt and Michael W. Bissell. These partnerships have further enriched his work and expanded the impact of his innovations in nucleic acid engineering.

Conclusion

Christopher Dolan's contributions to the field of genetic engineering through his patent and collaborations highlight his role as an innovator. His work continues to influence advancements in biotechnology and genetic modifications.